Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 18;7(6):e8130.
doi: 10.2196/mhealth.8130.

A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study

Affiliations

A Medication Adherence App for Children With Sickle Cell Disease: Qualitative Study

Kristina Curtis et al. JMIR Mhealth Uhealth. .

Abstract

Background: Young people with sickle cell disease (SCD) often demonstrate low medication adherence and low motivation for effectively self-managing their condition. The growing sophistication of mobile phones and their popularity among young people render them a promising platform for increasing medication adherence. However, so far, few apps targeting SCD have been developed from research with the target population and underpinned with theory and evidence.

Objective: The aim of this study was to develop a theory-and-evidence-based medication adherence app to support children and adolescents with SCD.

Methods: The Behavior Change Wheel (BCW), a theoretically based intervention development framework, along with a review of the literature, 10 interviews with children and adolescents with SCD aged between 12 and 18 years, and consultation with experts informed app development. Thematic analysis of interviews provided relevant theoretical and evidence-based components to underpin the design and development of the app.

Results: Findings suggested that some patients had lapses in memory for taking their medication (capability); variation in beliefs toward the effectiveness of medication and confidence in self-managing their condition (motivation); a limited time to take medication; and barriers and enablers within the changing context of social support during the transition into adulthood (opportunity). Steps were taken to select the appropriate behavioral change components (involving behavior change techniques [BCTs] such as information on antecedents, prompts/cues; self-monitoring of the behavior; and social support) and translate them into app features designed to overcome these barriers to medication adherence.

Conclusions: Patients with SCD have complex barriers to medication adherence necessitating the need for comprehensive models of behavior change to analyze the problem. Children and adolescents require an app that goes beyond simple medication reminders and takes into account the patient's beliefs, emotions, and environmental barriers to medication adherence.

Keywords: adolescents; children; mHealth; medication adherence; models, theoretical; sickle cell disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Avatar.
Figure 2
Figure 2
Avatar with clothes options.
Figure 3
Figure 3
Tip of the Day.
Figure 4
Figure 4
Daily Quiz.
Figure 5
Figure 5
Mood Tracker.
Figure 6
Figure 6
Medication Reminder.
Figure 7
Figure 7
Emergency card.

Similar articles

Cited by

References

    1. Issom D, Zosso A, Ehrler F, Wipfli R, Lovis C, Koch S. Exploring the challenges and opportunities of eHealth tools for patients with sickle cell disease. Stud Health Technol Inform. 2015;216:898. - PubMed
    1. Jacob E, Duran J, Stinson J, Lewis M, Zeltzer L. Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease. J Am Assoc Nurse Pract. 2013 Jan;25(1):42–54. doi: 10.1111/j.1745-7599.2012.00754.x. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539233/ - DOI - PMC - PubMed
    1. Estepp J, Winter B, Johnson M, Smeltzer M, Howard S, Hankins J. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatr Blood Cancer. 2014 Nov;61(11):2031–6. doi: 10.1002/pbc.25177. https://static.nichq.org/scdtdp/hydroxyurea-resources/TN%20TDP%20-%20Imp... - DOI - PubMed
    1. Silva I, Reis A, Palaré MJ, Ferrão A, Rodrigues T, Morais A. Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes. Eur J Haematol. 2015 Feb;94(2):157–61. doi: 10.1111/ejh.12411. https://comum.rcaap.pt/bitstream/10400.26/6705/1/artigo%20drepa%20final.pdf - DOI - PubMed
    1. Walsh K, Cutrona S, Kavanagh P, Crosby L, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014 Dec;134(6):1175–83. doi: 10.1542/peds.2014-0177. http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=2540... - DOI - PMC - PubMed

Publication types

MeSH terms